Platelet-Rich Plasma-Derived Growth Factor vs Hyaluronic Acid Injection in the Individuals with Knee Osteoarthritis: A One Year Randomized Clinical Trial

References

• Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obesity Rev. 2006;7(3):239–250. doi: 10.1111/j.1467-789X.2006.00251.x
   PubMed Web of Science ®Google Scholar
• Berenbaum F Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16–21. doi: 10.1016/j.joca.2012.11.012
   PubMed Web of Science ®Google Scholar
• Loeser RF, Goldring SR, Scanzello CR, Goldring MB Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64(6):1697–1707. doi: 10.1002/art.34453
   PubMed Web of Science ®Google Scholar
• Scanzello CR, Goldring SR The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–257. doi: 10.1016/j.bone.2012.02.012
   PubMed Web of Science ®Google Scholar
• Harvey WF, Hunter DJ The role of analgesics and intra-articular injections in disease management. Med Clin North Am. 2009;93(1):201–211, xii. doi: 10.1016/j.mcna.2008.07.010
   Web of Science ®Google Scholar
• Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KDJ Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468(1):57–63. doi: 10.1007/s11999-009-1119-9
   PubMed Web of Science ®Google Scholar
• Rayegani SM, Raeissadat SA, Heidari S. Safety M-JM and effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis. J Lasers Med Sci. 2017;8(Suppl 1):S12–S19. doi: 10.15171/jlms.2017.s3
   PubMedGoogle Scholar
• Sedighipour L, Raeissadat SA, Rayegani SM, Bossaghzadeh Z, Abdollahzadeh MH, Malayi F AB0973 The efficacy of electromyographic biofeedback on pain, function and maximal thickness of vastus medialis oblique muscle in patients with knee osteoarthritis: a randomised clinical trial. Ann Rheum Dis. 2018;77(Suppl 2):1610. doi: 10.1136/annrheumdis-2017-212762
   Web of Science ®Google Scholar
• Fransen M, McConnell S Exercise for osteoarthritis of the knee. Cochrane Database Sys Rev. 2008;4:Cd004376.
   Google Scholar
• Bjordal JM, Ljunggren AE, Klovning A, Slordal L Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ. 2004;329(7478):1317.
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162. doi: 10.1016/j.joca.2007.12.013
   PubMed Web of Science ®Google Scholar
• Marx RE Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–228. doi: 10.1097/00008505-200110000-00002
   PubMedGoogle Scholar
• Raeissadat SA, Rayegani SM, Hassanabadi H, et al. Knee osteoarthritis injection choices: platelet- rich plasma (PRP) versus hyaluronic acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015;8:1–8. doi: 10.4137/CMAMD.S17894
   PubMed Web of Science ®Google Scholar
• Raeissadat SA, Rayegani SM, Babaee M, Ghorbani E The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis. Pain Res Treat. 2013;2013:7. doi: 10.1155/2013/165967
   Google Scholar
• Raeissadat SA, Rayegani SM, Tabibian E, Rahimi Dehgolan S Intra-articular ozone injection efficacy in knee osteoarthritis: A systematic review with meta-analysis. Ann Phys Rehabil Med. 2018;61:e132–e133. doi: 10.1016/j.rehab.2018.05.294
   Google Scholar
• Rezasoltani Z, Taheri M, Mofrad MK, Mohajerani SA Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. J Pain Res. 2017;10:1179–1187. doi: 10.2147/JPR.S127633
   Web of Science ®Google Scholar
• Conrozier T, Jerosch J, Beks P, et al. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Orthop Trauma Surg. 2009;129(3):417–423. doi: 10.1007/s00402-008-0601-2
   PubMed Web of Science ®Google Scholar
• Navarro-Sarabia F, Coronel P, Collantes E, et al. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70(11):1957–1962. doi: 10.1136/ard.2011.152017
   PubMed Web of Science ®Google Scholar
• Altman RD, Rosen JE, Bloch DA, Hatoum HT Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label extension study of the FLEXX trial. Osteoarthritis Cartilage. 2011;19(10):1169–1175. doi: 10.1016/j.joca.2011.07.001
   PubMed Web of Science ®Google Scholar
• Pal S, Thuppal S, Reddy KJ, et al. Long-term (1-year) safety and efficacy of a single 6-mL injection of hylan G-F 20 in indian patients with symptomatic knee osteoarthritis. Open Rheumatol J. 2014;8:54–68. doi: 10.2174/1874312901408010054
   PubMedGoogle Scholar
• Askari A, Gholami T, NaghiZadeh MM, Farjam M, Kouhpayeh SA, Shahabfard Z Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail. Springer Plus. 2016;5:442. doi: 10.1186/s40064-016-2020-0
   Google Scholar
• Bruyere O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263. doi: 10.1016/j.semarthrit.2014.05.014
   PubMed Web of Science ®Google Scholar
• Hatoum HT, Fierlinger AL, Lin SJ, Altman RD Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain. J Med Econ. 2014;17(5):326–337. doi: 10.3111/13696998.2014.902843
   Google Scholar
• Raeissadat SA, Karimzadeh A, Hashemi M, Bagherzadeh L Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord. 2018;19(1):49.
   Web of Science ®Google Scholar
• Kon E, Filardo G, Delcogliano M, et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010;11:220. doi: 10.1186/1471-2474-11-220
   PubMed Web of Science ®Google Scholar
• Sanchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–1078.
   PubMed Web of Science ®Google Scholar
• Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surgery Sports Traumatol Arthroscopy. 2010;18(4):472–479. doi: 10.1007/s00167-009-0940-8
   PubMed Web of Science ®Google Scholar
• Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am j Phy Med Rehab. 2010;89(12):961–969. doi: 10.1097/PHM.0b013e3181fc7edf
   PubMed Web of Science ®Google Scholar
• Saad Setta H, Elshahat A, Elsherbiny K, Massoud K, Safe I Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wound J. 2011;8(3):307–312. doi: 10.1111/j.1742-481X.2011.00797.x
   PubMed Web of Science ®Google Scholar
• Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cusco X, Garcia-Balletbo M Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311–317. doi: 10.1007/s00402-010-1167-3
   PubMed Web of Science ®Google Scholar
• Raeissadat SA, Babaee M, Rayegani SM, et al. An overview of platelet products (PRP, PRGF, PRF, etc.) in the Iranian studies. Future Science OA. 2017;3(4):FSO231. doi: 10.4155/fsoa-2017-0045
   Web of Science ®Google Scholar
• Andia I, Sanchez M, Maffulli N Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther. 2012;12(1):7–22. doi: 10.1517/14712598.2012.632765
   PubMed Web of Science ®Google Scholar
• Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2(3):203–210. doi: 10.1177/1941738110366385
   PubMedGoogle Scholar
• Kon E, Filardo G, Di Martino A, Marcacci M Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surgery Sports Traumatol Arthroscopy. 2011;19(4):516–527. doi: 10.1007/s00167-010-1306-y
   PubMed Web of Science ®Google Scholar
• Mascarenhas R, Saltzman BM, Fortier LA, Cole BJ Role of platelet-rich plasma in articular cartilage injury and disease. J Knee Surg. 2015;28(1):3–10. doi: 10.1055/s-0034-1384672
   Web of Science ®Google Scholar
• Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surgery Sports Traumatol Arthroscopy. 2012;20(10):2082–2091. doi: 10.1007/s00167-011-1837-x
   PubMed Web of Science ®Google Scholar
• Sanchez M, Anitua E, Azofra J, Aguirre JJ, Andia I Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008;26(5):910–913.
   PubMed Web of Science ®Google Scholar
• Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy. 2013;29(10):1635–1643. doi: 10.1016/j.arthro.2013.07.264
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Nurden AT, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology. 2007;46(12):1769–1772. doi: 10.1093/rheumatology/kem234
   PubMed Web of Science ®Google Scholar
• Anitua E, Zalduendo MM, Prado R, Alkhraisat MH, Orive G Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. J Biomed Mater Res A. 2015;103(3):1011–1020. doi: 10.1002/jbm.a.35244
   PubMed Web of Science ®Google Scholar
• Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010;225(3):757–766. doi: 10.1002/jcp.22274
   PubMed Web of Science ®Google Scholar
• Coudriet GM, He J, Trucco M, Mars WM, Piganelli JD Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One. 2010;5(11):e15384. doi: 10.1371/journal.pone.0015384
   PubMed Web of Science ®Google Scholar
• Montaseri A, Busch F, Mobasheri A, et al. IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One. 2011;6(12):e28663. doi: 10.1371/journal.pone.0028663
   PubMed Web of Science ®Google Scholar
• Sakata R, McNary SM, Miyatake K, et al. Stimulation of the superficial zone protein and lubrication in the articular cartilage by human platelet-rich plasma. Am J Sports Med. 2015;43(6):1467–1473. doi: 10.1177/0363546515575023
   PubMed Web of Science ®Google Scholar
• Wu CC, Chen WH, Zao B, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011;32(25):5847–5854. doi: 10.1016/j.biomaterials.2011.05.002
   Web of Science ®Google Scholar
• Montanez-Heredia E, Irizar S, Huertas PJ, et al. Intra-articular injections of platelet-rich plasma versus hyaluronic acid in the treatment of osteoarthritic knee pain: a randomized clinical trial in the context of the spanish national health care system. Int J Mol Sci. 2016;17(7). doi: 10.3390/ijms17071064
   Web of Science ®Google Scholar
• Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–364. doi: 10.1177/0363546512471299
   PubMed Web of Science ®Google Scholar
• Filardo G, Di Matteo B, Di Martino A, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43(7):1575–1582. doi: 10.1177/0363546515582027
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, Aguirre JJ, Prado R, Padilla S, Orive G Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis. Arthroscopy. 2014;30(8):1006–1017.
   Web of Science ®Google Scholar
• Raeissadat SA, Rayegani SM, Ahangar AG, Abadi PH, Mojgani P, Ahangar OG Efficacy of intra-articular injection of a newly developed Plasma Rich in Growth Factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single-blinded randomized clinical trial. Clin Med Insights Arthritis Musculoskelet Disord. 2017;10:1179544117733452. doi: 10.1177/1179544117733452
   Web of Science ®Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840.
   PubMed Web of Science ®Google Scholar
• Lequesne MG, Mery C, Samson M, Gerard P Indexes of severity for osteoarthritis of the hip and knee. Validation–value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85–89. doi: 10.3109/03009748709102182
   PubMedGoogle Scholar
• Descalzi F, Ulivi V, Cancedda R, et al. Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism. Tissue Eng Part A. 2013; 19 (19–20): 2120–2129. doi: 10.1089/ten.tea.2012.0557
   PubMed Web of Science ®Google Scholar
• Dray A, Read SJ Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther. 2007;9(3):212. doi: 10.1186/ar2178
   PubMed Web of Science ®Google Scholar
• Richardson D, Pearson RG, Kurian N, et al. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther. 2008;10(2):R43.
   PubMed Web of Science ®Google Scholar
• Namiki O, Toyoshima H, Morisaki N Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol. 1982;20(11):501–507.
   PubMed Web of Science ®Google Scholar
• Leitner GC, Gruber R, Neumuller J, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. 2006;91(2):135–139. doi: 10.1111/j.1423-0410.2006.00815.x
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Lo GH The management of osteoarthritis: an overview and call to appropriate conservative treatment. Med Clin North Am. 2009;93(1):127–143, xi. doi: 10.1016/j.mcna.2008.07.009
   PubMed Web of Science ®Google Scholar
• Campbell J, Bellamy N, Gee T Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15(12):1424–1436. doi: 10.1016/j.joca.2007.01.022
   PubMed Web of Science ®Google Scholar
• Miller LE, Block JE US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:57–63. doi: 10.4137/CMAMD.S12743
   PubMedGoogle Scholar
• Duymus TM, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas FN Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options. Knee Surgery Sports Traumatol arthroscopy. 2017;25(2):485–492. doi: 10.1007/s00167-016-4110-5
   Web of Science ®Google Scholar
• Dai WL, Zhou AG, Zhang H, Zhang J Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659–670.e651.
   PubMed Web of Science ®Google Scholar
• Say F, Gurler D, Yener K, Bulbul M, Malkoc M Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chir Orthop Traumatol Cech. 2013;80(4):278–283.
   PubMed Web of Science ®Google Scholar
• Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40(12):2822–2827. doi: 10.1177/0363546512461902
   PubMed Web of Science ®Google Scholar
• Zou K, Wong J, Abdullah N, et al. Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2016;75(11):1964–1970. doi: 10.1136/annrheumdis-2015-208387
   PubMed Web of Science ®Google Scholar